Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q2 2016 · 10-Q
Revenue$516.80M$516.80M+2.1% vs Q2 2015 Net Income$16.60M$16.60M−41.5% vs Q2 2015 EPS Diluted$0.56$0.56−42.3% vs Q2 2015 Gross Profit$280,200,000+0.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flowderived$77,155,000+100.2% Free Cash Flowderived$45,586,000+618.6% Margins · derivedGross margin54.2%−1.0 pt vs Q2 2015
Operating margin5.2%−2.7 pt vs Q2 2015
Net margin3.2%−2.4 pt vs Q2 2015
ended Jun 30, 2016 · filed Aug 5, 2016 · 36 d after period end